Predicine is an internal clinical CSO (Contract Solution Organization) that provides first-in-class ctRNA and ctDNA combined liquid biopsy assay, to support global clinical trials, through Predicine's two CLIA certified service laboratories locates at San Francisco US, and Shanghai China. Currently three PrediSeq NGS panels are offered - Pan Cancer Panel, DNA Damage Repair Panel, and Cancer Immunotherapy Panel.